Taken together, the results with FasC194Vlpr/lpr transgenic mice make the prediction that the lymphadenopathy and accumulation of DN T cells characteristic of the Fas-deficient phenotype should only arise when there are defects in Fas-induced T-cell differentiation, and not just defective apoptosis. This evidence concerns the gene FAS and Lymphadenopathy.